237 related articles for article (PubMed ID: 17901052)
1. A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4.
Saito Y; Imazeki H; Miura S; Yoshimura T; Okutsu H; Harada Y; Ohwaki T; Nagao O; Kamiya S; Hayashi R; Kodama H; Handa H; Yoshida T; Fukai F
J Biol Chem; 2007 Nov; 282(48):34929-37. PubMed ID: 17901052
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.
Tanaka R; Seki Y; Saito Y; Kamiya S; Fujita M; Okutsu H; Iyoda T; Takai T; Owaki T; Yajima H; Taira J; Hayashi R; Kodama H; Matsunaga T; Fukai F
J Biol Chem; 2014 Jun; 289(25):17699-708. PubMed ID: 24808173
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4.
Saito Y; Owaki T; Matsunaga T; Saze M; Miura S; Maeda M; Eguchi M; Tanaka R; Taira J; Kodama H; Goto S; Niitsu Y; Terada H; Fukai F
J Biol Chem; 2010 Mar; 285(10):7006-15. PubMed ID: 20007695
[TBL] [Abstract][Full Text] [Related]
4. Biologically Active TNIIIA2 Region in Tenascin-C Molecule: A Major Contributor to Elicit Aggressive Malignant Phenotypes From Tumors/Tumor Stroma.
Iyoda T; Fujita M; Fukai F
Front Immunol; 2020; 11():610096. PubMed ID: 33362799
[TBL] [Abstract][Full Text] [Related]
5. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation.
Fujita M; Sasada M; Iyoda T; Nagai R; Kudo C; Yamamoto T; Osada S; Kodama H; Fukai F
Biochem Biophys Res Commun; 2021 Jan; 536():14-19. PubMed ID: 33360093
[TBL] [Abstract][Full Text] [Related]
6. Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.
Fujita M; Ito-Fujita Y; Iyoda T; Sasada M; Okada Y; Ishibashi K; Osawa T; Kodama H; Fukai F; Suzuki H
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195598
[TBL] [Abstract][Full Text] [Related]
7. Aggressive Progression in Glioblastoma Cells through Potentiated Activation of Integrin α5β1 by the Tenascin-C-Derived Peptide TNIIIA2.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Sasada M; Nagai R; Kudo C; Otsuka K; Kamiya S; Kodama H; Fukai F
Mol Cancer Ther; 2019 Sep; 18(9):1649-1658. PubMed ID: 31189613
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.
Saito Y; Shiota Y; Nishisaka M; Owaki T; Shimamura M; Fukai F
Biol Pharm Bull; 2008 May; 31(5):1003-7. PubMed ID: 18451535
[TBL] [Abstract][Full Text] [Related]
9. Autocrine Production of PDGF Stimulated by the Tenascin-C-Derived Peptide TNIIIA2 Induces Hyper-Proliferation in Glioblastoma Cells.
Fujita M; Yamamoto T; Iyoda T; Fujisawa T; Nagai R; Kudo C; Sasada M; Kodama H; Fukai F
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261783
[TBL] [Abstract][Full Text] [Related]
10. Clustering of syndecan-4 and integrin beta1 by laminin alpha 3 chain-derived peptide promotes keratinocyte migration.
Araki E; Momota Y; Togo T; Tanioka M; Hozumi K; Nomizu M; Miyachi Y; Utani A
Mol Biol Cell; 2009 Jul; 20(13):3012-24. PubMed ID: 19403697
[TBL] [Abstract][Full Text] [Related]
11. VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression.
Tanaka R; Owaki T; Kamiya S; Matsunaga T; Shimoda K; Kodama H; Hayashi R; Abe T; Harada YP; Shimonaka M; Yajima H; Terada H; Fukai F
J Biol Chem; 2009 Jul; 284(30):19817-25. PubMed ID: 19460753
[TBL] [Abstract][Full Text] [Related]
12. Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation.
Iyoda T; Ohishi A; Wang Y; Yokoyama MS; Kazama M; Okita N; Inouye S; Nakagawa Y; Shimano H; Fukai F
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339104
[TBL] [Abstract][Full Text] [Related]
13. The cell adhesion and proliferation activities of a peptide derived from human tenascin-C are dependent on two Ile residues.
Hayashi R; Miura S; Saito Y; Osada S; Iyoda T; Fukai F; Kodama H
Bioorg Med Chem; 2012 Aug; 20(15):4608-13. PubMed ID: 22776297
[TBL] [Abstract][Full Text] [Related]
14. Induction of cellular senescence in fibroblasts through β1-integrin activation by tenascin-C-derived peptide and its protumor effect.
Fujita M; Sasada M; Eguchi M; Iyoda T; Okuyama S; Osawa T; Tsuzuranuki K; Sakamoto M; Hagihara Y; Matsumura M; Osada S; Kodama H; Higami Y; Fukai F
Am J Cancer Res; 2021; 11(9):4364-4379. PubMed ID: 34659892
[TBL] [Abstract][Full Text] [Related]
15. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression.
Fujita M; Suzuki H; Fukai F
World J Gastrointest Oncol; 2021 Sep; 13(9):980-994. PubMed ID: 34616507
[TBL] [Abstract][Full Text] [Related]
16. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.
Fujita M; Sasada M; Iyoda T; Fukai F
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708610
[TBL] [Abstract][Full Text] [Related]
18. Laminin-1 and laminin-2 G-domain synthetic peptides bind syndecan-1 and are involved in acinar formation of a human submandibular gland cell line.
Hoffman MP; Nomizu M; Roque E; Lee S; Jung DW; Yamada Y; Kleinman HK
J Biol Chem; 1998 Oct; 273(44):28633-41. PubMed ID: 9786856
[TBL] [Abstract][Full Text] [Related]
19. Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways.
Whiteford JR; Behrends V; Kirby H; Kusche-Gullberg M; Muramatsu T; Couchman JR
Exp Cell Res; 2007 Nov; 313(18):3902-13. PubMed ID: 17870067
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.
Iyoda T; Fukai F
Int J Cell Biol; 2012; 2012():647594. PubMed ID: 22216033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
